The relationship between serum uric acid level and glycosylated hemoglobin in patients with type 2 diabetes mellitus

doi:10.3877/cma.j.issn.2095-655X.2018.01.014

Abstract

Abstract:

Objective

To explore the relationship between serum uric acid (SUA) level and glycosylated hemoglobin (HbA1c) level of patients with type 2 diabetes mellitus.

Methods

One thousand three hundred and thirty one patients with type 2 diabetes mellitus were collected from the endocrinology department of Weishan people's Hospital from January 2014 to December 2016.The serum uric acid and glycated hemoglobin levels was detected, and the correlation was analyzed by Pearson correlation analysis.According to the HbA1c levels of different genders, each gender group was divided into 3 groups: HbA1c≤7%, 7%<HbA1c<10%, HbA1c≥10%.The SUA levels were compared by one-way analysis of variance.

Results

SUA levels were (303.15±87.73)μmol/L, (285.32±77.87)μmol/L, (256.82±84.42)μmol/L in male group, respectively (F=13.55, P<0.01), SUA levels were (295.45±82.41)μmol/L, (267.26±76.59)μmol/L, (245.28±93.81)μmol/L in female, respectively (F=17.14, P<0.01). There were significant differences among the three groups.SUA levels were negatively correlated with HbA1c level (male: r=-0.23, female: r=-0.21).

Conclusion

There is a negative correlation between the expression of SUA and HbA1c.Patients with diabetes must pay attention to SUA level while lowering blood sugar.

Key words: Hemoglobin A, glycosylated, Uric acid, Diabetes mellitus, type 2

Xiaoe Li, Xuewei Liu, Yuting Li. The relationship between serum uric acid level and glycosylated hemoglobin in patients with type 2 diabetes mellitus[J]. Chinese Journal of Diagnostics(Electronic Edition), 2018, 06(01): 65-68.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2018.01.014

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2018/V06/I01/65

Figures/Tables 2

References 20

[1]	Ford ES，Li C，Cook S，et al.Serum concentrations of uric acid and the metabo1ic syndrome among US children and adolescents[J]．Circulation，2007，115(19):2526-2532.
[2]	Schretlen DJ，Inscore AB，Vannorsdall TD，et al.Serum uric acid and brain ischemia in normal elderly adults[J]．Neurology，2007，69(14):1418-1423.
[3]	Siu YP，Leung KT，Tong MK，et al.Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level[J]．Am J Kidney Dis，2006，47(1):51-59.
[4]	WHO.Definition，diagnosis and classification of diabetes mellitus and its complications-Part 1: diagnosis and classification of diabetes mellitus[S]．Geneva：WHO.1999.
[5]	毛玉山，周丽诺，黄童，等．高SUA血症患病率与代谢综合征组分数的关系[J]．中国糖尿病杂志，2008，16(3):154-155.
[6]	Bonakdaran S, Kharaqani B．Association of serum uric acid and metabolic syndrome in type 2 diabetes[J]．Curr Diabetes Rev，2014，10(2):113-117.
[7]	王梦卉，张瑜，骆秦，等．高血压合并糖尿病住院患者原发性醛固酮增多症的筛检及随访[J/CD]．中华诊断学电子杂志，2017，5(2):93-97.
[8]	Verdoia M, Barbieri L, Schaffer A，et al.Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study[J]．Metabolism，2014，63(5):640-646.
[9]	Panero F，Gruden G，Perotto M，et al.Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study[J]．Atherosclerosis，2012，221(1):183-188.
[10]	Feig DI，Soletsky B，Johnson RJ.Effect of allopurinol on blood pressure of adolescents with newly diagnosed essentialhypertension：a randomized trial[J]．JAMA，2008，300(8):924-932.
[11]	Kim SY，Guevara JP，Kim KM，et al.Hyperuricemia and coronary heart disease：a systematic review and meta-analysis[J]．Arthritis care Res(Hoboken)，2010，62(2):170-180.
[12]	Verdoia M, Schaffer A, Cassetti E, et al.Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus[J]．Am J Prev Med，2014，47(1):9-16.
[13]	苏东峰，宋娜，王英南，等.2型糖尿病患者糖化血红蛋白水平与SUA排泄分数的相关性研究[J]．中国糖尿病杂志，2015，23(6),540-542.
[14]	白雪凤，林夏鸿.2型糖尿病患者HbA1c与血尿酸的相关关系[J]．福建医学杂志，2017，39(2):63-66.
[15]	张楠，万钢，吕玉洁，等.2型糖尿病高尿酸血症与代谢综合征相关性的研究[J]．国际检验学杂志，2016，37(18):2583-2586.
[16]	马少瑾，刘长山.2型糖尿病患者高尿酸血症的相关危险因素及与胰岛素抵抗的相关性分析[J]．青岛医药卫生，2016，48(2),85-87.
[17]	王颜刚，苗志敏，闰胜利，等．高SUA血症及痛风病人血SUA与胰岛素抵抗的关系[J]．青岛大学医学院学报，2004，40(3):197-199.
[18]	吴媛媛，李军，李思源，等．不同糖耐量患者糖化血红蛋白与胰岛素抵抗的相关性研究[J]．中国糖尿病杂志，2013，21(12),1066-1068.
[19]	Cigolini M，Targher G，Tonoli M，et al.Hyperuricaemia：relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women[J]．Int J Obes Relat Metab Disord，1995，19(2):92-96.
[20]	Nan H，Dong Y，Gao W，et al.Diabetes associated with a low serum uric acid level in a general Chinese population[J]．Diabetes Res Clin Pract，2007，76(1):68-74.

项目	HbA1c≤7%(n＝163)	7%<HbA1c<10%(n＝292)	HbA1c≥10%(n＝162)	F值	P值
年龄(岁)	68.61±9.46	64.47±11.26	62.59±12.83^ab	12.40	<0.01
CR(μmol/L)	63.11±15.87	61.16±15.84^a	55.37±16.33^a	10.63	<0.01
β2-MG(mg/L)	2.39±0.94	2.25±0.80	2.16±0.86^a	3.16	<0.05
TG(mmol/L)	1.67±1.39	2.11±1.67^a	1.72±1.37^b	10.15	<0.01
CHOL(mmol/L)	4.88±1.08	4.98±1.19	5.10±1.39	1.34	>0.05
LP(a)(mg/L)	298.02±217.00	271.17±188.00	261.73±196.00	2.39	>0.05
HDL-C(mmol/L)	1.33±0.33	1.22±0.35	1.28±0.34^a	5.13	<0.01
VLDL-C(mmol/L)	0.84±0.46	0.94±0.57	0.87±0.49	2.33	>0.05
LDL-C(mmol/L)	2.71±0.72	2.83±0.81	2.97±0.99^a	4.10	<0.05
APOA1/APOB	1.41±0.55	1.31±0.54	1.31±0.60	1.78	>0.05
SUA(μmol/L)	303.15±83.73	285.32±77.87^a	256.82±84.42^ab	13.55	<0.01

项目	HbA1c≤7%(n＝163)	7%<HbA1c<10%(n＝292)	HbA1c≥10%(n＝162)	F值	P值
年龄(岁)	68.61±9.46	64.47±11.26	62.59±12.83^ab	12.40	<0.01
CR(μmol/L)	63.11±15.87	61.16±15.84^a	55.37±16.33^a	10.63	<0.01
β2-MG(mg/L)	2.39±0.94	2.25±0.80	2.16±0.86^a	3.16	<0.05
TG(mmol/L)	1.67±1.39	2.11±1.67^a	1.72±1.37^b	10.15	<0.01
CHOL(mmol/L)	4.88±1.08	4.98±1.19	5.10±1.39	1.34	>0.05
LP(a)(mg/L)	298.02±217.00	271.17±188.00	261.73±196.00	2.39	>0.05
HDL-C(mmol/L)	1.33±0.33	1.22±0.35	1.28±0.34^a	5.13	<0.01
VLDL-C(mmol/L)	0.84±0.46	0.94±0.57	0.87±0.49	2.33	>0.05
LDL-C(mmol/L)	2.71±0.72	2.83±0.81	2.97±0.99^a	4.10	<0.05
APOA1/APOB	1.41±0.55	1.31±0.54	1.31±0.60	1.78	>0.05
SUA(μmol/L)	303.15±83.73	285.32±77.87^a	256.82±84.42^ab	13.55	<0.01

项目	HbA1c≤7%(n＝165)	7%<HbA1c<10%(n＝323)	HbA1c≥10%(n＝226)	F值	P值
年龄(岁)	58.07±11.04	57.64±10.30^a	53.41±10.89^a	13.11	<0.01
CR(μmol/L)	57.92±13.53	53.12±15.54^a	46.65±13.44^ab	30.26	<0.01
β2－MG(mg/L)	2.11±0.87	2.09±0.82^a	1.84±0.73^a	8.02	<0.01
TG(mmol/L)	1.87±1.51	2.33±1.80	2.00±1.63^ab	5.21	<0.01
CHOL(mmol/L)	4.82±1.12	5.31±1.26^a	5.44±1.47^a	11.95	<0.01
LP(a)(mg/L)	280.56±207.00	272.07±195.00	316.82±408.00	2.78	>0.05
HDL-C(mmol/L)	1.24±0.29	1.27±0.29	1.39±0.55^ab	8.93	<0.01
VLDL-C(mmol/L)	0.90±0.48	1.05±0.64^a	1.02±0.68^a	3.45	<0.05
LDL-C(mmol/L)	2.72±0.79	2.98±0.91^a	3.04±0.94^a	6.91	<0.01
APOA1/APOB	1.38±0.51	1.29±0.55	1.25±0.57	2.41	>0.05
SUA(μmol/L)	295.45±82.41	267.26±76.59^a	245.28±93.81^ab	17.14	<0.01

项目	HbA1c≤7%(n＝165)	7%<HbA1c<10%(n＝323)	HbA1c≥10%(n＝226)	F值	P值
年龄(岁)	58.07±11.04	57.64±10.30^a	53.41±10.89^a	13.11	<0.01
CR(μmol/L)	57.92±13.53	53.12±15.54^a	46.65±13.44^ab	30.26	<0.01
β2－MG(mg/L)	2.11±0.87	2.09±0.82^a	1.84±0.73^a	8.02	<0.01
TG(mmol/L)	1.87±1.51	2.33±1.80	2.00±1.63^ab	5.21	<0.01
CHOL(mmol/L)	4.82±1.12	5.31±1.26^a	5.44±1.47^a	11.95	<0.01
LP(a)(mg/L)	280.56±207.00	272.07±195.00	316.82±408.00	2.78	>0.05
HDL-C(mmol/L)	1.24±0.29	1.27±0.29	1.39±0.55^ab	8.93	<0.01
VLDL-C(mmol/L)	0.90±0.48	1.05±0.64^a	1.02±0.68^a	3.45	<0.05
LDL-C(mmol/L)	2.72±0.79	2.98±0.91^a	3.04±0.94^a	6.91	<0.01
APOA1/APOB	1.38±0.51	1.29±0.55	1.25±0.57	2.41	>0.05
SUA(μmol/L)	295.45±82.41	267.26±76.59^a	245.28±93.81^ab	17.14	<0.01

Please choose a citation manager

Content to export